US EditionPresident Trump’s Weed Order Sounds Big. The Reality Is More Complicated
The federal government aims to enhance cannabis research and increase profits for companies, with little immediate impact on consumer prices, industry sources say.
- A renewed federal push to relax marijuana restrictions is underway, which industry participants say will boost cannabis-company profits and expand research for patients and researchers.
- Political filings show cannabis interests donated at least $2 million to Trump-linked committees and spent roughly $3.2 million on lobbyists supporting the effort.
- Lobbyists and political operatives include Brian Ballard, Bryan Lanza, and Daniel McFaul, while American Rights and Reform PAC is funded by Curaleaf and Green Thumb Industries; GOP consultant Alex Bruesewitz accepted $300,000 from the PAC.
- Supporters, including law enforcement and veterans groups at an Oval Office signing, said the action paves the way for new treatments for patients, while Congressional Republicans pushed back and watchdogs accused pay-for-play; the White House denied impropriety.
- A Curaleaf photo dated Nov. 8, 2022 shows active cultivation at the Curaleaf cannabis growing facility in Litchfield and retail grows like the 3D Cannabis Center in Denver.
9 Articles
9 Articles
2025 Unfiltered: Moments that marked Colorado's decidedly off-kilter political
From the flurry of executive orders that ushered in President Donald Trump's second term to a blizzard of lawsuits filed by the state's Democratic officials, the state's political year was marked by near-constant conflict between the GOP-controlled f
Marijuana companies spent millions ahead of Trump’s executive order
Political committees, consultants, and lobbyists linked to President Donald Trump made out with millions of dollars in payments from the marijuana industry in the months leading up to his executive order demanding the substance’s reclassification, according to public records reviewed by the Washington Examiner. The United States Cannabis Council and American Rights and Reform PAC, a pair of pro-marijuana interest groups, alongside leading cannab…
Federal push to relax marijuana classification should help the industry in Illinois, but the effects for consumers may take time
President Trump’s executive order didn't legalize cannabis, but directed officials to change its classification as a controlled substance to Schedule III, the same class as codeine, ketamine and steroids.
Coverage Details
Bias Distribution
- 60% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
